DarioFabianMirskiMD

PubMed

• 21 citations
  Impact of oral antipsychotic medication adherence on healthcare resource utilization among schizophrenia patients with Medicare coverage.
  Steve Offord, Jay Lin, Bruce Wong, Dario Mirski, Ross A. Baker> ;Community Mental Health Journal. 2013 Aug 10
• 40 citations
  Healthcare Cost Reductions Associated with the Use of LAI Formulations of Antipsychotic Medications Versus Oral Among Patients with Schizophrenia
  Jay Lin, Bruce Wong, Steve Offord, Dario Mirski> ;The Journal of Behavioral Health Services & Research. 2013 Apr 12
• 52 citations
  Impact of Early Nonadherence to Oral Antipsychotics on Clinical and Economic Outcomes Among Patients with Schizophrenia
  Steve Offord, Jay Lin, Dario Mirski, Bruce Wong> ;Advances in Therapy. 2013 Mar 8
• 49 citations
  Healthcare resource usage of schizophrenia patients initiating long-acting injectable antipsychotics vs oral.
  Steve Offord, Bruce Wong, Dario Mirski, Ross A. Baker, Jay Lin> ;Journal of Medical Economics. 2013 Jan 1
• 15 citations
  A pilot study evaluating the efficacy and safety of rivastigmine in patients with mixed dementia.
  Steven G. Potkin, Gus Alva, Ibrahim Gunay, Barbara Koumaras, Michael Chen, Dario Mirski> ;Drugs & Aging. 2006 Jan 1
• 9 citations
  The validation of a caregiver assessment of dementia: the Dementia Severity Scale.
  Philip D. Harvey, Patrick J Moriarty, Leah Kleinman, Karin Coyne, Carl H. Sadowsky, Michael Chen, Dario Mirski> ;Alzheimer Disease and Associated Disorders. 2005 Oct 1
• 69 citations
  Effects of rivastigmine treatment on the neuropsychiatric and behavioral disturbances of nursing home residents with moderate to severe probable Alzheimer's disease: a...
  Jeffrey L. Cummings, Barbara Koumaras, Michael Chen, Dario Mirski> ;The American Journal of Geriatric Pharmacotherapy. 2005 Sep 1
• 16 citations
  The Use of the Occupational Disruptiveness Scale of the Neuropsychiatric Inventory-Nursing Home Version to Measure the Impact of Rivastigmine on the Disruptive Behavio...
  Hind T. Hatoum, Swu-Jane Lin, Stephen Arcona, Simu K. Thomas, Barbara Koumaras, Dario Mirski> ;Journal of the American Medical Directors Association. 2005 Jul 1
• 19 citations
  Switching From Donepezil to Rivastigmine Is Well Tolerated: Results of an Open-Label Safety and Tolerability Study
  Carl H. Sadowsky, Martin R. Farlow, Leone Atkinson, Jennifer Steadman, Barbara Koumaras, Michael Chen, Dario Mirski> ;Primary Care Companion to the Journal of Clinical Psychiatry. 2005 Apr 1
• 14 citations
  Long-term effects of rivastigmine treatment on the need for psychotropic medications in nursing home patients with Alzheimer's disease : results of a 52-week open-labe...
  Keith Edwards, Barbara Koumaras, Michael Chen, Ibrahim Gunay, Dario Mirski> ;Clinical Drug Investigation. 2005 Jan 1
• 40 citations
  Long-term effects of rivastigmine treatment on neuropsychiatric and behavioral disturbances in nursing home residents with moderate to severe Alzheimer's disease: resu...
  Peter M. Aupperle, Barbara Koumaras, Michael Chen, Adrian L. Rabinowicz, Dario Mirski> ;Current Medical Research and Opinion. 2004 Aug 26
• 28 citations
  Impact of Rivastigmine Use on the Risk of Nursing Home Placement in a US Sample
  Kathleen M. Beusterien, Simu K. Thomas, Douglas Gause, Miriam Kimel, Stephen Arcona, Dario Mirski> ;CNS Drugs. 2004 Jan 1
• 20 citations
  Risk of Antipsychotic Drug Use in Patients with Alzheimer’s Disease Treated with Rivastigmine
  Dong-Churl Suh, Stephen Arcona, Simu K. Thomas, Christopher Powers, Adrian L. Rabinowicz, Hyunchul Shin, Dario Mirski> ;Drugs & Aging. 2004 Jan 1
• 53 citations
  Analysis of outcome in retrieved dropout patients in a rivastigmine vs placebo, 26-week, Alzheimer disease trial.
  Martin R. Farlow, Steven G. Potkin, Barbara Koumaras, Jeffrey Veach, Dario Mirski> ;Archives of Neurology. 2003 Jun 1
• 5 citations
  Behavioral and psychological signs and symptoms of dementia: a practicing psychiatrist's viewpoint.
  Jacobo Mintzer, Dario F. Mirski, Kathleen S. Hoernig> ;Dialogues in Clinical Neuroscience. 2000 Jun 1
• 23 citations
  Fenfluramine challenge test as a marker of serotonin activity in patients with alzheimer’s dementia and agitation
  Jacobo Mintzer, Olga Brawman-Mintzer, Dario F. Mirski, Richard Unger, Paul J. Nietert, Allison Meeks, Royce R. Sampson> ;Biological Psychiatry. 1998 Nov 1
• 18 citations
  Treatment of Agitation in Patients with Dementia
  Jacobo Mintzer, Kathleen S. Hoernig, Dario F. Mirski> ;Clinics in Geriatric Medicine. 1998 Feb 1
• Effects of rivastigmine on cognitive function in patients with traumatic brain injury.
  Silver, J. M., Koumaras, B., Chen, M., Mirski, D., Potkin, S. G., Reyes, P., Warden, D., Harvey, P. D., Arciniegas, D., Katz, D. I., Gunay, I.> ;Neurology. 2006 Sep 12
• Join now to see all